We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Patterns of Circulating MicroRNAs Characterize Lack of Sleep in Children and Adolescents

By LabMedica International staff writers
Posted on 20 Jan 2020
Print article
Image: Sleeping children: “Zwei schlafende Mädchen auf der Ofenbank” (1895) by Albert Anker (Photo courtesy of Wikimedia Commons)
Image: Sleeping children: “Zwei schlafende Mädchen auf der Ofenbank” (1895) by Albert Anker (Photo courtesy of Wikimedia Commons)
A major pan-European study established a link between circulating microRNAs and sleep duration in children and adolescents.

It is commonly recognized that sleep is essential for children's health, and that insufficient sleep duration is associated with negative health consequences, such as heart disease and diabetes. In humans, sleep duration and quality are influenced by genetic, environmental, and social factors. Likewise, epigenetic mechanisms regulate circadian rhythms and sleep patterns.

Investigators participating in the I.Family Study, which includes 17 member institutes in 12 countries, sought to determine if differential patterns of circulating miRNAs were associated with sleep duration in normal‐weight European children and adolescents. The I.Family Study, which is administered from the University of Bremen (Germany) was set up to “provide insight into the most important influences on Europe’s young people, their lifestyle behaviors and their eating habits as they move into adolescence”.

For this study, 111 normal‐weight European children and adolescents (from Spain, Italy, Cyprus, Germany, Belgium, Estonia, Hungary, and Sweden) participating in the I.Family Study, were divided into two groups based upon self‐reported sleep duration, according to the recommended amount of sleep for pediatric populations. Minimum normal sleep time for children younger than 13 years was set at nine hours per day and for children older than 13 at eight hours per day. Levels of microRNAs were determined following extraction from blood samples in single assays performed in triplicate by real‐time quantitative PCR (RT‐qPCR).

MicroRNAs (miRNAs) and short interfering RNAs (siRNA) comprise a class of about 20 nucleotides-long RNA fragments that block gene expression by attaching to molecules of messenger RNA in a fashion that prevents them from transmitting the protein synthesizing instructions they had received from the DNA. With their capacity to fine-tune protein expression via sequence-specific interactions, miRNAs help regulate cell maintenance and differentiation. In addition to miRNAs playing an essential role in tumor development, dysregulation of certain miRNAs has been associated with many different diseases, such as dementia, and cardiovascular conditions.

Results revealed that sleep duration reflected the profile of specific circulating miRNAs in school‐aged children and adolescents. Group differences (short sleepers versus normal sleepers) were found in circulating levels of miR‐26b‐3p and miR‐485‐5p, adjusting for country of origin, age, sex, pubertal status, screen time and highest educational level of parents.

"Our findings show for the first time that the sleep duration reflects the profile of specific circulating microRNAs in school-aged children and adolescents. This could allow clinicians to easily determine if children are sleeping enough by using a simple blood test and use this as an indication of other aspects of their health," said contributing author Dr. Fabio Lauria, a researcher at the Italian Institute of Food Sciences (Rome, Italy).

The study was published in the January 8, 2020, online edition of the journal Experimental Physiology.

Related Links:
University of Bremen
I.Family Study
Institute of Food Sciences


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Real-time PCR System
GentierX3 Series

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: The study showed the blood-based cancer screening test detects 83% of people with colorectal cancer with specificity of 90% (Photo courtesy of Guardant Health)

Blood Test Shows 83% Accuracy for Detecting Colorectal Cancer

Colorectal cancer is the second biggest cause of cancer deaths among adults in the U.S., with forecasts suggesting 53,010 people might die from it in 2024. While fewer older adults are dying from this... Read more

Hematology

view channel
Image: The Gazelle Hb Variant Test (Photo courtesy of Hemex Health)

First Affordable and Rapid Test for Beta Thalassemia Demonstrates 99% Diagnostic Accuracy

Hemoglobin disorders rank as some of the most prevalent monogenic diseases globally. Among various hemoglobin disorders, beta thalassemia, a hereditary blood disorder, affects about 1.5% of the world's... Read more

Microbiology

view channel
Image: The new platform is designed to perform blood-based diagnoses of nontuberculosis mycobacteria (Photo courtesy of 123RF)

New Blood Test Cuts Diagnosis Time for Nontuberculous Mycobacteria Infections from Months to Hours

Breathing in nontuberculous mycobacteria (NTM) is a common experience for many people. These bacteria are present in water systems, soil, and dust all over the world and usually don't cause any problems.... Read more

Industry

view channel
Image: These new assays are being developed for use on the recently introduced DxI 9000 Immunoassay Analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter and Fujirebio Expand Partnership on Neurodegenerative Disease Diagnostics

Beckman Coulter Diagnostics (Brea, CA, USA) and Fujirebio Diagnostics (Tokyo, Japan) have expanded their partnership focused on the development, manufacturing and clinical adoption of neurodegenerative... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.